March 25 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE ANNOUNCES FDA ALLOWANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CG-806
* APTOSE BIOSCIENCES INC - PHASE 1 TRIAL IN RELAPSED OR REFRACTORY CLL AND B CELL MALIGNANCIES PLANNED TO INITIATE IN Q2/2019